Your browser doesn't support javascript.
loading
Defining the landscape of circular RNAs in neuroblastoma unveils a global suppressive function of MYCN.
Fuchs, Steffen; Danßmann, Clara; Klironomos, Filippos; Winkler, Annika; Fallmann, Jörg; Kruetzfeldt, Louisa-Marie; Szymansky, Annabell; Naderi, Julian; Bernhart, Stephan H; Grunewald, Laura; Helmsauer, Konstantin; Rodriguez-Fos, Elias; Kirchner, Marieluise; Mertins, Philipp; Astrahantseff, Kathy; Suenkel, Christin; Toedling, Joern; Meggetto, Fabienne; Remke, Marc; Stadler, Peter F; Hundsdoerfer, Patrick; Deubzer, Hedwig E; Künkele, Annette; Lang, Peter; Fuchs, Jörg; Henssen, Anton G; Eggert, Angelika; Rajewsky, Nikolaus; Hertwig, Falk; Schulte, Johannes H.
Afiliação
  • Fuchs S; Department of Pediatric Oncology and Hematology, Charité - Universitätsmedizin Berlin, 13353, Berlin, Germany. steffen.fuchs@charite.de.
  • Danßmann C; The German Cancer Consortium (DKTK), Partner Site Berlin, 10117, Berlin, Germany. steffen.fuchs@charite.de.
  • Klironomos F; The German Cancer Research Center (DKFZ), 69120, Heidelberg, Germany. steffen.fuchs@charite.de.
  • Winkler A; Berlin Institute of Health at Charité - Universitätsmedizin Berlin, 10178, Berlin, Germany. steffen.fuchs@charite.de.
  • Fallmann J; CRCT, Inserm, CNRS, Université Toulouse III-Paul Sabatier, Centre de Recherches en Cancérologie de Toulouse, Université de Toulouse, 31037, Toulouse, France. steffen.fuchs@charite.de.
  • Kruetzfeldt LM; Laboratoire d'Excellence Toulouse Cancer-TOUCAN, 31037, Toulouse, France. steffen.fuchs@charite.de.
  • Szymansky A; Department of Pediatric Oncology and Hematology, Charité - Universitätsmedizin Berlin, 13353, Berlin, Germany.
  • Naderi J; Department of Pediatric Oncology and Hematology, Charité - Universitätsmedizin Berlin, 13353, Berlin, Germany.
  • Bernhart SH; Department of Pediatric Oncology and Hematology, Charité - Universitätsmedizin Berlin, 13353, Berlin, Germany.
  • Grunewald L; Bioinformatics Group, Department of Computer Science, and Interdisciplinary Center for Bioinformatics, University of Leipzig, 04107, Leipzig, Germany.
  • Helmsauer K; Department of Pediatric Oncology and Hematology, Charité - Universitätsmedizin Berlin, 13353, Berlin, Germany.
  • Rodriguez-Fos E; Department of Pediatric Oncology and Hematology, Charité - Universitätsmedizin Berlin, 13353, Berlin, Germany.
  • Kirchner M; Department of Pediatric Oncology and Hematology, Charité - Universitätsmedizin Berlin, 13353, Berlin, Germany.
  • Mertins P; Department of Genome Regulation, Max Planck Institute for Molecular Genetics, 14195, Berlin, Germany.
  • Astrahantseff K; Bioinformatics Group, Department of Computer Science, and Interdisciplinary Center for Bioinformatics, University of Leipzig, 04107, Leipzig, Germany.
  • Suenkel C; Department of Pediatric Oncology and Hematology, Charité - Universitätsmedizin Berlin, 13353, Berlin, Germany.
  • Toedling J; The German Cancer Consortium (DKTK), Partner Site Berlin, 10117, Berlin, Germany.
  • Meggetto F; The German Cancer Research Center (DKFZ), 69120, Heidelberg, Germany.
  • Remke M; Experimental and Clinical Research Center (ECRC) of the Charité and Max-Delbrück-Center for Molecular Medicine (MDC) in the Helmholtz Association, 13125, Berlin, Germany.
  • Stadler PF; Department of Pediatric Oncology and Hematology, Charité - Universitätsmedizin Berlin, 13353, Berlin, Germany.
  • Hundsdoerfer P; Experimental and Clinical Research Center (ECRC) of the Charité and Max-Delbrück-Center for Molecular Medicine (MDC) in the Helmholtz Association, 13125, Berlin, Germany.
  • Deubzer HE; Core Unit Proteomics, Berlin Institute of Health at Charité - Universitätsmedizin Berlin and Max Delbrück Center for Molecular Medicine (MDC), 13125, Berlin, Germany.
  • Künkele A; Core Unit Proteomics, Berlin Institute of Health at Charité - Universitätsmedizin Berlin and Max Delbrück Center for Molecular Medicine (MDC), 13125, Berlin, Germany.
  • Lang P; Department of Pediatric Oncology and Hematology, Charité - Universitätsmedizin Berlin, 13353, Berlin, Germany.
  • Fuchs J; Systems Biology of Gene Regulatory Elements, Berlin Institute for Medical Systems Biology, Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Hannoversche Straße 28, 10115, Berlin, Germany.
  • Henssen AG; Lonza Drug Product Services, 4057, Basel, Switzerland.
  • Eggert A; Department of Pediatric Oncology and Hematology, Charité - Universitätsmedizin Berlin, 13353, Berlin, Germany.
  • Rajewsky N; The German Cancer Consortium (DKTK), Partner Site Berlin, 10117, Berlin, Germany.
  • Hertwig F; The German Cancer Research Center (DKFZ), 69120, Heidelberg, Germany.
  • Schulte JH; CRCT, Inserm, CNRS, Université Toulouse III-Paul Sabatier, Centre de Recherches en Cancérologie de Toulouse, Université de Toulouse, 31037, Toulouse, France.
Nat Commun ; 14(1): 3936, 2023 07 04.
Article em En | MEDLINE | ID: mdl-37402719
ABSTRACT
Circular RNAs (circRNAs) are a regulatory RNA class. While cancer-driving functions have been identified for single circRNAs, how they modulate gene expression in cancer is not well understood. We investigate circRNA expression in the pediatric malignancy, neuroblastoma, through deep whole-transcriptome sequencing in 104 primary neuroblastomas covering all risk groups. We demonstrate that MYCN amplification, which defines a subset of high-risk cases, causes globally suppressed circRNA biogenesis directly dependent on the DHX9 RNA helicase. We detect similar mechanisms in shaping circRNA expression in the pediatric cancer medulloblastoma implying a general MYCN effect. Comparisons to other cancers identify 25 circRNAs that are specifically upregulated in neuroblastoma, including circARID1A. Transcribed from the ARID1A tumor suppressor gene, circARID1A promotes cell growth and survival, mediated by direct interaction with the KHSRP RNA-binding protein. Our study highlights the importance of MYCN regulating circRNAs in cancer and identifies molecular mechanisms, which explain their contribution to neuroblastoma pathogenesis.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: RNA Circular / Neuroblastoma Limite: Child / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: RNA Circular / Neuroblastoma Limite: Child / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article